HFA 2019: Updates From the ESC HFA EORP HF Long-Term Registry

Published: 10 Jun 2019

  • Views:

    Views Icon 121
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Dr Chris J Kapelios (Laiko General Hospital, Athens, GR) discusses sacubitril / valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long-term Registry: bridging between the PARADIGM HF trial, ESC Guidelines and the real world.


Why did you conduct this analysis?

How did you collect and analyse the data?

What were your findings?

How should this study influence practice and research with Sacubitril/valsartan?

Interviewer: Liam O'Neill

Videographer: Mike Knight

Filmed on site at HFA 2019.